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A naturally occurring bovine model with excess follicular fluid androstenedione (High A4), reduced fertility, and
polycystic ovary syndrome (PCOS)-like characteristics has been identified. We hypothesized High A4 granulosa
cells (GCs) would exhibit altered cell proliferation and/or steroidogenesis. Microarrays of Control and High A4
GCs combined with Ingenuity Pathway Analysis indicated that High A4 GCs had cell cycle inhibition and
increased expression of microRNAs that inhibit cell cycle genes. Granulosa cell culture confirmed that A4
treatment decreased GC proliferation, increased anti-Müllerian hormone, and increased mRNA for CTNNBIP1.
Increased CTNNBIP1 prevents CTNNB1 from interacting with members of the WNT signaling pathway thereby
inhibiting the cell cycle. Expression of CYP17A1 was upregulated in High A4 GCs presumably due to reduced FOS
mRNA expression compared to Control granulosa cells. Furthermore, comparisons of High A4 GC with thecal and
luteal cell transcriptomes indicated an altered cellular identity and function contributing to a PCOS-like
phenotype.

1. Introduction
It is well established that high androgen concentrations, both
circulating and within the ovary, are associated with ovarian dysfunc
tion and systemic metabolic issues. Ovarian hyperandrogenism as seen
with polycystic ovary syndrome (PCOS) causes symptoms such as hir
sutism, anovulation, and metabolic dysfunction (which also compounds
fertility problems) (Azziz et al., 2009; Hayek et al., 2016; Padwal, 2020;
Rosenfield and Ehrmann, 2016). Other causes of hyperandrogenism

such as congenital adrenal hyperplasia also result in reproductive dis
ruptions (e.g. precocious puberty), virilization, and metabolic syn
dromes (Azziz et al., 2004; Hayek et al., 2016; Merke and Bornstein,
2005; Rosenfield and Ehrmann, 2016). Androgens affect many systems,
including the hypothalamic-pituitary-gonadal axis. Disrupted regulation
of gonadotropin releasing hormone and gonadotropins are sufficient to
substantially impact fertility (Bateman and Patisaul, 2008; Dierich et al.,
1998; Viau, 2002). There are also local effects of androgens on the
follicular cells within the ovary. The theca cells of the follicle are

Abbreviations: A4, androstenedione; GCs, granulosa cells; IPA, Ingenuity Pathway Analysis; LLCs, large luteal cells; PCA, Principal Component Analysis; PCOS,
Polycystic Ovary Syndrome; SLCs, small luteal cells; TCs, theca cells; AMH, Anti-Mullerian Hormone; CTNNB1, beta-catenin; CTNNBIP1, catenin beta interacting
protein 1; WNT, wingless-type mouse mammary tumor virus integration site.
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primarily responsible for converting cholesterol to androgens, while the
granulosa cells (GCs) convert thecal androgens to estrogens (Mason
et al., 1994; Young and McNeilly, 2010). However, bovine GCs also
express enzymes that can convert 17-hydroxy-pregnenolone to the an
drogens dehydroepiandrosterone (DHEA) and androstenedione (A4) in a
steroid synthesis pathway that is shared between humans and cattle
(Conley et al., 1995; Conley and Bird, 1997). Human and bovine GCs
also express the androgen receptor and can thus respond to local an
drogens as well as produce them (Hampton et al., 2004; Luo and Wilt
bank, 2006).
It can be difficult to isolate local ovarian versus systemic effects on
fertility in most clinical cases of hyperandrogenism because there is a
broad spectrum of symptoms (Azziz et al., 2004; Balen et al., 1995).
Many cases of infertility can occur without excessive circulating an
drogens (Hayek et al., 2016; Padwal, 2020; Rosenfield and Ehrmann,
2016) and mild cases of sporadic anovulation can go undetected. Ex
amination of a cohort of normally menstruating women demonstrated
that 8–13% of these ‘normal’ women were not consistently ovulating for
two consecutive reproductive cycles (Hambridge et al., 2013; Lynch
et al., 2014). While infertility and sporadic anovulation can have a
plethora of causes, high local concentrations of androgens not accom
panied by high circulating concentrations of androgens may be a
contributing factor to these disorders.
Cattle are a monovulatory species with similar reproductive cycles to
those of women making them an excellent research model for ovarian
physiology. In fact, beef cows have many similar ovarian problems
(Abedaj-Majed and Cupp, 2019). These issues include the spontaneous
development of ovarian cysts and chronic or sporadic anovulation in
approximately 10% of females (Smith, 2015; Summers et al., 2014;
Wiltbank et al., 2002). A population of beef cows within the University
of Nebraska-Lincoln research herd has been identified with both a theca
cell molecular phenotype similar to that seen in women with PCOS and
excessive intrafollicular A4, the predominant androgen in cattle (Sum
mers et al., 2014). These cows exhibit excess concentrations of A4 in
their follicular fluid (>30 fold higher than controls). Additionally, these
cows lack an increase in estradiol (E2) production of similar magnitude
to the follicular A4 concentrations (only 2–4 fold higher) (Summers
et al., 2014).
The identification of this phenotype presents a novel opportunity to
identify the local ovarian effects of naturally-occurring androgen excess
in vivo. The primary cause of the increased A4 was identified as excessive
steroidogenesis in the theca cells of the dominant follicle (Summers
et al., 2014). The effects of those androgens and how they can lead to
anovulation have been further investigated by assessing the conse
quences for the GCs of those same dominant follicles.

MARC III) were synchronized with two injections of prostaglandinF2α
(PGF2α) 14 days apart and transrectal ultrasound-guided ovarian follicle
aspiration was performed 12–36 h after the final PGF2α injection as
previously described (Summers et al., 2014) and Fig. 1.
The synchronization protocol in Fig. 1 is the most “natural” syn
chronization method that does not introduce steroids into the cow to
alter development of the dominant follicle. Instead, it uses a normally
expressed factor PGF2α to lyse the corpus luteum causing the most
advanced follicle to initiate growth and development to an ovulatory
stage follicle which can be aspirated 12–36 h later and A4 measured in
ff.
Follicles aspirated 12–36 time points after PGF2α would not be ex
pected to have been exposed to a luteinizing hormone (LH) surge. Pre
vious experiments in our cattle have shown that the LH surge occurs
56–72 h after PGF2α administration (data not shown) while others have
shown that the LH surge occurs > 42 h post-PGF2α (Guilbault et al.,
1988; Nkuuhe and Manns 1985). The follicular fluid of the dominant
follicle was aspirated and separated from GCs by centrifugation. Sub
sequent radioimmunoassay for E2 and enzyme-linked immunosorbent
assay (ELISA) for A4 were performed as previously described (Summers
et al., 2014). Based on these assays, follicles with a high A4 concentra
tion ([A4] ≥40 ng/mL) and no corresponding increase in [E2] were
classified as “High A4”, while follicles with an average/Control con
centration (A4 ≤20 ng/mL) and average [E2] were classified as “Low
A4” and designated as Controls.
2.3. Ovariectomy, follicle aspiration and isolation of somatic cells from
Control and High A4 cows for microarray analysis
Ovariectomy was performed approximately 36 h after CIDR removal
(Youngquist et al., 1995). Upon ovariectomy, one follicle, the dominant,
largest (>10 mm diameter) antral follicle from each cow’s ovaries was
aspirated/dissected and the GCs (≥94% purity; Romereim et al., 2017)
and follicular fluid were isolated as previously described (Summers
et al., 2014). Follicles with a follicular fluid E2:P4 ratio greater than 1
were classified as estrogen-active (EA; Echternkamp et al., 2004; Sun
derland et al., 1994). After checking that the largest follicle was EA, the
granulosa cells were then used for the microarray and subsequent
quantitative real-time PCR (qPCR), GCs were homogenized in
Tri-reagent (Sigma-Aldrich) for RNA isolation.
2.4. Microarray transcriptome analysis
Four cows with follicular fluid [A4] at the highest end of the High A4
group (mean A4 = 356 ng/mL, SD = 148; range 203–597 ng/mL) and
four cows with follicular fluid [A4] at the lowest end of the Control

2. Methods
2.1. 1a. Ethics statement
All animals were humanely treated and cared for in accordance with
University of Nebraska-Lincoln IACUC guidelines. The University of
Nebraska-Lincoln is fully AAALAC accredited and follows NIH guide
lines. Transcriptomes of granulosa cells were evaluated in this study.
Only females were used in the current study since we are interested in
the mechanisms involved with granulosa cell function, which is only
present in female mammalian species.
2.2. 1b. Cow classification

Fig. 1. Synchronization Protocol to obtain follicular fluid from dominant
estrogen-active follicles to classify High A4 and Control (Low A4) cows for
study. The estrous cycles of these beef cows (75% Red Angus, 25% MARC III)
were synchronized with two injections of prostaglandinF2α (PGF2α) 14 days
apart and transrectal ultrasound-guided ovarian follicle aspiration was per
formed 12–36 h after the final PGF2α injection as previously described (Sum
mers et al., 2014).

A multi-year, multiple estrous cycle survey of 26 randomly selected
cows was performed to characterize reproductive phenotypes in the
University of Nebraska-Lincoln physiology herd located at the Eastern
Nebraska Research and Extension Center (ENREC) formerly known as
the Agriculture Research and Development Center (ARDC) (Summers
et al., 2014). The estrous cycles of these beef cows (75% Red Angus, 25%
2
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group (mean A4 = 1.9 ng/mL, SD = 0.39; range 1.40–2.50 ng/mL) were
selected for GC transcriptome analysis. After RNA extraction, 200 ng
RNA for each sample (n = 4 animals for each group) were submitted to
the University of Nebraska Medical Center Microarray Core facility
where the Affymetrix Bovine GeneChip® Gene 1.0 ST Array RNA
expression analysis was performed. Full transcriptome data is available
from the NCBI GEO repository, Series GSE97017. The microarray results
were normalized with Robust Multi-Array Averaging. Array analysis was
then performed using the National Institute of Aging array tool (NIA)
(http://lgsun.grc.nia.nih.gov/ANOVA/) for Analysis of Variance
(ANOVA) to determine hierarchical clustering, and correlation between
replicates. All bioinformatic analyses were performed on transcripts
above a linear noise threshold of 100. Functional categorization of genes
was determined by examining the gene descriptions from Entrez Gene
(NCBI, http://www.ncbi.nlm.nih.gov/gene) and UniProtKB/Swiss-Prot
(http://www.uniprot.org/). Predicted cell function outcomes were
assessed with Ingenuity® Pathway Analysis (IPA; Winter 2016 release,
Qiagen, 2021 January update). Potential miRNA targets were deter
mined using TargetScan Release 7.1 (June 2016) for mammalian
microRNAs (http://www.targetscan.org/vert_71/). The Principal
Component Analysis was performed in NIA array tool (http://lgsun.grc.
nia.nih.gov/ANOVA/) demonstrating the differences in High A4 and
Control GCs with small and large luteal cells. Small and large luteal cells
were previously compared to determine lineage differences with control
GCs via NIA array and a PCA script (Romereim et al., 2016).

(11,054–001, LifeTech)] and F12 [with L-glutamine (11,765–054,
LifeTech)] with 1% penicillin/streptomycin (15,140–122, LifeTech) and
2% FBS (26,140–079, LifeTech). Cells were cultured overnight (14–18
h) in this medium, and then incubated for 4 h in serum-free medium
with 1% ITS supplement (51,500–056, LifeTech). The cells were then
cultured with serum-free medium plus 1% ITS. Treatments were: 1)
Control (PBS with no FSH or A4), 2) bovine Follicle Stimulating Hor
mone (0.1 IU/μL) (FSH; AFP-9294C, National Hormone and Peptide
Program) reconstituted in sterile PBS; 3) FSH plus 4-androsten-3, 17dione (A6030-000, Steraloids) reconstituted in ethanol and then diluted
in PBS prior to addition to culture media at 1 nM (0.29 ng/mL); 4) FSH
plus A4 at 100 nM (28.6 ng/mL); and 5) FSH plus A4 at 1 μM (286 ng/
mL). Control and FSH-only media had a volume of ethanol added
equivalent to that included with the highest A4 treatment (10 μL ethanol
in 500 μL media). Cells were incubated with treated media for 20–22 h,
and then cells were either lysed with RIPA buffer containing Halt™
protease inhibitor cocktail (78,430, Thermo Fisher Scientific) for west
ern blots or collected for RNA isolation utilizing Tri-Reagent (Sigma) as
previously described. Two collections of bovine slaughterhouse ovaries
were used with three replicates per treatment for all A4 concentrations.
Culture media was collected at end of culture and stored at − 80 C for
analysis of factors secreted in media.
2.7. Droplet digital PCR for Catenin Beta Interacting Protein 1
(CTNNBIP1)
To determine differences in gene expression of Catenin Beta Inter
acting Protein 1 (CTNNBIP1), droplet digital PCR (ddPCR) was per
formed in duplicate on 96-well plates to amplify select targets from
cDNA synthesized with iScript Advanced (Bio-Rad) from the RNA
samples collected from slaughterhouse GC cultures using the primers
listed in Table 2. EvaGreen Master Mix (Bio-Rad) was used and droplets
were generated utilizing DG6 cartridge (Bio-Rad) and droplet generator
oil for EvaGreen Supermix (Bio-Rad). After droplets were generated,
they were placed into a 96-well plate and amplified with the C1000
Touch Thermal Cycler (Bio-Rad). Once the PCR run was completed,
droplets were read utilizing the QX200 Droplet reader (Bio-Rad) to
count number of positive and negative droplets per sample. Concen
trations were determined per sample volume and expression was
normalized to 100 copies of RNA products of RPL12. A Student’s t-test
was used to determine differences between groups with P < 0.05 set for
significance.

2.5. Quantitative real-time PCR (qPCR)
To validate the microarray results, qPCR was performed in triplicate
on 384-well plates to amplify select targets from cDNA synthesized with
Superscript III Reverse Transcriptase (Thermo Fisher Scientific) from the
RNA samples originally used for the microarray using the primers listed
in Table 1. Power SYBR™ Green Master Mix (Thermo Fisher Scientific)
was utilized with an Applied Biosystems 7900HT Fast Real-Time PCR
System. Expression was normalized to the geometric mean of the ribo
somal RNA products RPL15 and RPL19. The results for each transcript
are represented as the geometric mean of fold-changes relative to the
expression of that transcript in the Control GCs.
2.6. Primary granulosa cell culture
For cell culture experiments to determine effects of A4 concentration
on granulosa cells, GCs were isolated from ovaries obtained at a local
abattoir (JBS, Omaha, NE). Follicles larger than 7 mm in diameter were
aspirated, the follicular fluid was centrifuged (300×g) 10 min to pellet
the GCs, and the GC pellet was digested for 15–20 min with a mixture of
dispase (10 mL, Stem Cell Technologies), collagenase (final concentra
tion of 1 mg/mL, Stem Cell Technologies), and DNase I (final concen
tration of 10 μg/mL, Stem Cell Technologies). The cells suspended in
digestion media were then diluted with culture media (DMEM/F12
containing 2% FBS and 1% penicillin/streptomycin), counted using a
Scepter 2.0 Cell Counter (EMD Millipore), and centrifuged to pellet the
cells again. The cell pellet was resuspended with culture media and
distributed into 6-well plates at a density of 500,000 cells per well in a
1:1 mixture of DMEM [low glucose and no phenol red or L-glutamine

2.8. AMH ELISA
Spent culture media from GC Controls, those treated with FSH, and
FSH plus A4 100 nM (28.6 ng/mL) was analyzed utilizing a commer
cially available bovine AMH ELISA kit (Ansh Labs, Ca# AL-114). For the
analysis, culture media was not diluted and followed the manufacture’s
protocol. The intra-assay CV was 1.96%. A Student’s t-test was utilized
to determine differences between groups with P < 0.05 set for
significance.

Table 1
qPCR Primers.
Primer

Accession Number

Forward

Reverse

CCNA2
CYP17A1
CYP19A1
ECT2
RPL15
RPL19

NM_001075123.1
NM_174304.2
NM_174305.1
NM_001097573.1
NM_001077866.1
NM_001040516.2

AAGCTGGCCTGAATCATTAGTA
GACTCCAGCATTGGCGACCT
TTCAACAGCAGAGAAGCTGGAA
AGGAATGGCGGTAACGGTGA
TGGAGAGTATTGCGCCTTCTC
CAGACGATACCGTGAATCTAAGAAGA

TCTGAGGTAGGTCTGGTGAA
GGGATGCTGCCACTCCTTCT
CCACGTTTCTCAGCAAAAATCA
ATGATGGCACTCGCAAAGGAC
CACAAGTTCCACCACACTATTGG
TGAGAATCCGCTTGTTTTTGAA

3
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Table 2
ddPCR primers utilized for CTNNBIP1 and RPL12 transcripts.
Primer

Accession number

Forward

Reverse

CTNNBIP1
RPL12

XM_024976736.1
NM_205797.1

TTCTTGTCAGCAAACGCAGGT
CCACCATGCCGCCTAAGTTC

TTTGTCGCCAGAGCCAAGGT
TTTGGAGACAGACCCAGAGGGC

2.9. Western blotting and protein quantification – GC proliferation

Table 3
Primary and secondary antibodies for western blotting.

The cell lysates in RIPA buffer plus protease inhibitors were sepa
rated by size on a 10% polyacrylamide gel using a BioRad MINI-Protean
system according to the manufacturer’s instructions. The separated
proteins were transferred to Immobilon-FL membranes (EMD Millipore),
blocked for 2 h using Odyssey® Blocking Buffer (927–40000, LI-COR),
and then incubated in Odyssey® Blocking Buffer plus 1% Tween-20
and the primary antibody (rabbit anti-ACTB antibody, 4967S, Cell
Signaling Technology; rabbit anti-PCNA antibody, ab29, Abcam;
Table 3) overnight at 4 ◦ C with agitation. After TBST (tris buffered saline
- Tween 20) washes, blots were incubated in Odyssey® Blocking Buffer
plus 1% Tween-20 plus the secondary antibody (IRDye 680CW goat antirabbit IgG, 926–68071, LI-COR, Table 3) for 1–2 h at room temperature
with agitation. Final TBST and TBS washes were followed by blot image
acquisition using the LI-COR Odyssey® CLx Imaging System. To quan
tify the relative amount of protein expressed in each sample, the density
of each protein band in pixels was determined using ImageJ (http://i
magej.nih.gov/ij/). ImageJ is a free analysis program that allows for
density of protein bands to be quantitated by the number of dark pixels
on a scanned image. ImageJ then was used in conjunction with the file of
the blot from the LI-COR Odyssy Imaging System to quantitate protein
bands using the square tool in ImageJ which measures density of pixels
within the protein band. The density of the protein band for each sample
was normalized using the density of ACTB and averaged over culture
experiments. Data were analyzed with prism and an ANOVA was used to
determine the effect of increased concentration of A4 on PCNA staining
(a measure of proliferation) in granulosa cells. To determine differences
between Control and dose of A4 or between A4 doses, Sidaks multiple
comparisons test with planned comparisons was utilized. The main
comparisons of interest were – 1) comparison of Control (non-treated
GCs) vs FSH plus 1 μM A4 (286.4 ng/mL; similar to High A4 cow ff); and
2) FSH plus 1 μM A4 (286.4 ng/mL-similar to High A4 ff concentrations)
vs FSH plus A4 1 nM (0.29 ng/mL; similar to Control cow ff A4 con
centrations). Differences in data were considered to be statistically sig
nificant at P ≤ 0.05.

Protein

Primary Antibody

Dilution

Substrate

ACTB

mouse monoclonal IgG1

1:10,000

Cell Signaling Technology
(4967S)

1:2000

West
Femto
West Pico

MAPK1/3

rabbit polyclonal IgG
Cell Signaling Technology
(9102)

1:500

N/A

1:1000

West Pico

p-MAPK1/3

rabbit monoclonal IgG
Cell Signaling Technology
(4370)

1:2000

West Pico

FOXO1

rabbit polyclonal IgG
Abcam (ab39656)

1:1000

West Pico

p-FOXO1

rabbit polyclonal IgG
Cell Signaling Technology
(9461)

1:1000

West Pico

PCNA

mouse monoclonal IgG
Abcam (ab29)
rabbit monoclonal IgG

1:1000

N/A

1:8000

West
Femto

1:8000

West
Femto

1:8000

West
Femto

p-AKT1

Cell Signaling Technology
(4060)
CTNNB1

mouse monoclonal IgG1
BD Transduction
Laboratory (610,154)

Non-pCTNNB1

mouse monoclonal IgG1K

Specificity

Secondary Antibody

Dilution

Substrate

anti-mouse

horseradish peroxidaselinked IgG
Cell Signaling Technology
(7076)

1:10,000

West
Femto

horseradish peroxidaselinked IgG
Cell Signaling Technology
(7074)

1:10,000
1:2000

West
Femto
West Pico

IRDye 680CW IgG
LI-COR (926–68071)

1:5000

N/A

2.10. Western blotting and protein quantification – GC signaling of
granulosa cell cultures and high A4 and control cows after estrous cycle
synchronization and aspiration
Anti-rabbit

Granulosa cells were aspirated in dominant follicles after estrous
cycle synchronization was conducted as described (Fig. 2 except no
ovariectomy) to evaluate GCs from EA follicles in the naturally occurring
high-androgen microenvironment compared to Controls. Transrectal
ultrasound-guided follicle aspiration, rather than ovariectomy, was
performed as previously described (Summers et al., 2014, Fig. 2).
Aspirated samples were immediately centrifuged (300×g) for 10 min.
After centrifugation, the follicular fluid was decanted from the resulting
GC pellet. Centrifugation and decanting were repeated and GCs were
then snap frozen in liquid nitrogen for western blotting.
Protein was extracted from GCs using RIPA buffer with protease in
hibitors. Proteins were separated by size on a 10% polyacrylamide gel
and transferred to Immobilon PVDF membranes (EMD Millipore) for
protein detection. Membranes were blocked with 5% milk in TBST prior
to overnight incubation with primary antibody (rabbit anti-AKT1 anti
body, 9272, Cell Signaling Technology; rabbit anti-phospho-AKT anti
body, 4060, Cell Signaling Technology; rabbit anti-FOXO1 antibody,
ab39656, Abcam; rabbit anti-phospho-FOXO1 antibody, 9461, Cell

Anti-rabbit

Millipore (05–665)

1:20,000 (with
ACTB 1◦ Ab)
1:2000

West Pico

ACTB = actin, beta; AKT1 = v-akt murine thymoma viral oncogene homolog 1;
CTNNB1 = beta catenin; MAPK1/3 = mitogen-activated protein kinase 1 and 3;
FOXO1 = forkhead box O1; PCNA = proliferating cell nuclear antigen; p =
phosphorylated.

Signaling Technology; mouse anti-CTNNB1 antibody, 610,154, BD;
mouse anti-active-CTNNB1 antibody, 05–665, EMD Millipore; rabbit
anti-MAPK1/3 antibody, 9102, Cell Signaling Technology; rabbit-antiphospho-MAPK1/2; 4370, Cell Signaling Technology, Table 3). Mem
branes were rinsed with TBST and incubated with the secondary anti
body (anti-mouse IgG, 7076, Cell Signaling Technology; anti-rabbit IgG,
7074, Cell Signaling Technology). Either SuperSignal West Pico
4
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2.12. Collection and fixation of antral follicles
For histology of ovarian follicles, antral follicles (>7 mm diameter)
were isolated from ovaries obtained at a local abattoir (JBS, Omaha,
NE). Isolated follicles were placed in chilled 4% paraformaldehyde and
fixed overnight at 4 ◦ C rocking. Follicles were then washed 3 times with
1x PBS for 5 min at 4 ◦ C rocking and then incubated overnight in 1x PBS
containing 30% sucrose at 4 ◦ C rocking. The following day, half of the
sucrose solution was removed and an equal volume of Optimal Cutting
Temperature (OCT) compound (Thermo Fisher Scientific) was added
and the tissue was incubated for 3 h at 4 ◦ C rocking. Follicles were then
arranged at the bottom of a plastic mold filled with OCT and placed in a
mixture of dry ice and 70% ethanol to allow the samples to freeze. All
embedded samples were then stored at − 80 ◦ C until sectioning. Follicles
were sectioned at a thickness of 20 μm and mounted on slides for
immunostaining.

Fig. 2. Synchronization protocol for obtaining granulosa cells for microarray
analysis in the High A4 and Control groups. Estrous cycles of cows were syn
chronized with a modified Co-Synch protocol using gonadotropin releasing
hormone (GnRH) and a controlled internal drug release device (CIDR; 1.38 g
progesterone, Zoetis) for 7 days with a PGF2α (25 mg/mL; Lutalyse, Zoetis)
injection at CIDR removal (Summers et al., 2014). This protocol was utilized so
all follicle waves that developed would be more synchronized and the dominant
follicles would be at similar stages of development to allow for less variation
with gene expression in individual follicles from each cow for the micro
array analysis.

2.13. Follicle and GC immunohistochemistry for steroidogenic enzymes

Chemiluminesent Substrate (Pierce) (FOXO1, phospho-FOXO1,
MAPK1/3, phospho-MAPK1/3, Table 3) or SuperSignal West Femto
Maximum Sensitivity Substrate (Pierce) (AKT1, phosphor-AKT1,
CTNNB1, active-CTNNB1, Table 3) was added to the membranes and
protein bands were visualized following exposure on x-ray film.
Following initial transfer, blots were stripped with Restore Western
Blot Stripping Buffer (Pierce), re-blocked, and incubated with a mouse
monoclonal primary antibody against beta actin (mouse anti-ACTB
antibody, 4967, Cell Signaling Technology, Table 3). Following a
TBST rinse, membranes were incubated with the secondary antibody
(anti-mouse IgG, 7076, Cell Signaling Technology, Table 3) and protein
bands were visualized as previously described. Quantification was
conducted as described above except band density was measured using
Adobe Photoshop. A Student’s t-test was used to compare means among
three different experiments; differences in data was considered to be
statistically significant at P ≤ 0.05.

For immunohistochemistry of FSH stimulated GCs from High A4 and
Control cows and slaughterhouse follicles, sections and cells were fixed
with 4% paraformaldehyde for 10 min at room temperature. Slides were
washed three times for 5 min in 1x PBS and then permeabilized with
0.1% Tween-20 in PBS for 10 min. Slides were then washed for 5 min
with 1x PBS, then blocked in 30% BSA in PBST (0.05% Tween-20 in 1x
PBS) for 80 min at room temperature. Slides were incubated with a
primary antibody (mouse anti-aromatase, 1:100, ab139492, Abcam;
rabbit anti-CY17A1, 1:50, ABC 392 EMD Millipore) in 3% BSA in PBST
overnight at 4 ◦ C. Slides were washed 5 times for 5 min with 1x PBST
and then incubated with a secondary antibody (Alexa Fluor 555 goat
anti-mouse IgG, 1:1000, Thermo Fisher Scientific; Alexa Fluor 488
donkey anti-rabbit IgG, 1:1000, A21206, Thermo Fisher Scientific) in
3% BSA in PBST for 2.5 h. Slides were washed 3 times for 5 min in 1x
PBST, incubated with DAPI (5 ng/mL) in 1x PBS for 5 min and then
washed 3 times for 5 min with PBS. Slides were mounted with Prolong
Gold with Antifade (Thermo Fisher Scientific) and sealed. Slides were
imaged at the University of Nebraska-Lincoln Microscopy Core using the
Olympus FV3000 laser scanning confocal microscope. Localization of
CYP17A1 and CYP19A1 was quantified using ImageJ and approximate
percentages were reported for granulosa cell staining.

2.11. Collection and fixation of GCs after FSH stimulation
To obtain histology from GCs in EA follicles from Control and High
A4 cows, estrous cycles were synchronized and stimulated with FSH
(Fig. 3).
Aspirates were centrifuged to remove ff from granulosa cells and
pellets were resuspended with PBS. After the cell pellet was suspended,
aliquots of 105 GCs (n = 4 replicates per animal) were placed on ice and
washed twice with 2% FCS-PBS. Cell pellets were diluted in 100 μl
chilled 1% BSA-PBS. Cytospin slides were prepared based on manufac
turer’s instructions (Statspin CytoFuge 2, HemoCue America). Diluted
cells were aliquoted 100 μl in to each well, the lid was placed over the
samples and spun at maximum speed (1060×g) for 2 min. Filters were
gently removed from slides to prevent smearing and slides were exam
ined to ensure cells annealed properly. Slides were then dried in a
desiccation chamber overnight.

3. Results
3.1. A high-androgen follicular microenvironment generates differentially
regulated transcripts in granulosa cells
During a multi-year, multiple estrous cycle survey to classify bovine
reproductive phenotypes, the GCs and follicular fluid from dominant
follicles were isolated (Summers et al., 2014). The purity of GCs was
determined using immunofluorescence (IF) against smooth muscle
actin, which is a marker for contaminating theca cells (≥94% in our
preparation) (Romereim et al., 2016). Based on the previously published

Fig. 3. Synchronization protocol to stimulate GCs
in vivo with FSH and develop multiple follicles to
obtain GCs. Cow estrous cycles were synchronized
to collect GCs after FSH for histology via a cytospin
centrifuge allowing for individual cells to be
adhered onto slides and the identification of mul
tiple co-labeled steroid enzyme antibodies. Cows
were administered two PGF2α injections 14 days
apart, transrectal ultrasound-guided aspiration of
the dominant follicle was performed (Summers
et al., 2014) on day 10 after the last PGF2α to allow for increased follicles to develop (and increased GCs) in response to FSH. Immediately after, a series of FSH
injections (20 mg/mL injection; 140 mg/mL total; Folltropin-V, Vetoquinol) were given 12 h apart over a 4-day period. On day 12 and 13 of the protocol, PGF2α was
administered to stimulate regression of any luteal tissue and allow for continued development of antral follicles. Ovariectomy (Youngquist et al., 1995) was per
formed approximately 24 h after the last PGF2α injection and all antral follicles larger than 7 mm in diameter were aspirated.
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classifications of the androgen content of the follicular fluid (Summers
et al., 2014), GC samples were selected and utilized for Affymetrix RNA
microarray analysis [NCBI GEO GSE97017]. Hierarchical clustering of
overall transcriptomes demonstrated that GCs can be distinguished by
the androgen content of their follicle-of-origin (Fig. 4A). While the
Control or High A4 status of the GCs can be determined by their tran
scriptomes, the list of differentially regulated transcripts between the
two categories is surprisingly limited once statistical thresholds (P <
0.005, false discovery rate (FDR) < 0.05, linear noise threshold of 100)
are applied and unannotated probes are omitted, leaving 60 upregulated
transcripts and 210 downregulated transcripts (Data in Brief, Snider
et al., XXXXXXXX). The differentially regulated transcripts with highest
fold-changes between High A4 and Control GCs are shown in Table 4. A
full list of the differentially expressed genes can be found in Snider et al.
XXXXXXX (Data in Brief). Select genes were validated by qPCR (Fig. 4B).
We also previously validated differential expression of several genes
between control GCs and other ovarian somatic cells (Romereim et al.,
2016).

same scale as the highest A4 content of follicles from High A4 cows (286
ng/mL or 1 μM). After 20–22 h of treatment with FSH and/or A4,
Western blot was performed to quantify the proliferation marker PCNA
normalized to beta actin (ACTB) (Fig. 6). Treatment with A4 caused
reduced PCNA in granulosa cells treated with FSH plus 1 μM (290 ng/
mL) of A4 compared to FSH plus 1 nM (0.29 ng/mL) A4 similar to that
found in Control cows. Also the GCs treated with FSH plus 1 μM (286 ng/
mL) also had reduced PCNA when compared to GCs with no FSH or A4
treatment (Fig. 6).
3.3. Potential regulators of inhibition of granulosa proliferation
The IPA software was used to predict changes in upstream regulators
(activation or inhibition) based on the expression differences observed
in target downstream genes. Based on the differentially regulated tran
scripts in the High A4 GCs compared to the Control GCs, potential up
stream regulators of inhibited cell proliferation were identified (Data in
Brief, Snider et al., XXXX). Additionally, this analysis was used to un
cover possible regulatory mechanisms that could be driving the tran
scriptome changes in the High A4 GCs.
Several predicted miRNAs that may regulate the expression of
differentially regulated genes in High A4 granulosa cells were identified.
Ten miRNAs were upregulated in the High A4 GCs, and one miRNA was
downregulated (Table 6; with fold expression values identified in
microarray analysis, NIA array tool and IPA). Using TargetScan, 118
downregulated mRNAs (112 annotated) from the microarray analysis
were predicted as targets of the upregulated miRNAs (Data in Brief,
Snider et al., XXXX). Many of these miRNAs can potentially regulate
more than one mRNA transcripts. The functions of these 112 annotated
genes are primarily associated with mitosis and the cell cycle, meta
bolism, and transcription regulation (Fig. 7).

3.2. High-A4 microenvironment results in decreased expression of
proliferation markers
The differentially regulated transcripts of the High A4 GCs compared
to the Control GCs provided insights regarding functional differences
between the two sets of cells. Using the Ingenuity Pathway Analysis
(IPA) software, a list of predicted networks with functional significance
in High A4 compared to control granulosa cells were identified
(Table 5). The predictions suggested that the High A4 GCs had inhibited
proliferation, cell cycle progress, and cell survival compared to the
Control GCs. These IPA predictions were supported by the assessment of
the functional annotations of all the differentially regulated genes based
on Entrez and UniProKB databases. The categories with the highest
representation, based on the 60 upregulated mRNAs, were miRNA, cell
signaling, and immune function genes (Fig. 5A). The most represented
categories, based on the 210 downregulated genes, were those involved
in mitosis and the cell cycle, cellular metabolism, and transcription
regulation (Fig. 5B).
To confirm that reduced GC proliferation (the main predicted
outcome for High A4 GCs) was due to the excess A4 in the follicular fluid
rather than some other variable, primary GCs obtained from large antral
follicles of ovaries from a local abattoir were cultured and treated with
control media, bovine FSH, or bovine FSH and one of three concentra
tions of A4. The lowest concentration of A4 is on the same order of
magnitude as the A4 content of the follicular fluid of the Control cows
(0.29 ng/mL or 1 nM), while the highest concentration of A4 is on the

3.4. High-A4 microenvironment resulted in altered signaling pathway
activation
Slaughterhouse GC’s treated with 100 nM A4 compared to controls
(182.0 ± 4.59 vs 146.0 ± 5.68 pg/mL, respectively) (Fig. 8A) had
increased AMH production. AMH produced from GCs can inhibit
Wingless-type mouse mammary tumor virus integration site (WNT)
signaling pathway by production of CTNNBIP1 (Zhang et al., 2015). The
WNT signaling pathway is one of the major established cellular prolif
eration pathways. This pathway was therefore investigated in slaugh
terhouse GCs treated with increased concentrations of A4 to that in High
A4 cow follicular fluid. We also evaluated mRNA abundance of
CTNNBIP1 since this molecule inhibits active beta catenin from
Fig. 4. Transcriptome comparison between High
and Control GCs. (A) Hierarchical clustering of the
transcriptomes identified that the High A4 GCs
cluster together and the Control GCs cluster
together. The distance along the x-axis at which
each branching point occurs represents how similar
or dissimilar each sample is, with more similar
samples branching closer to 0. (B) Microarray vali
dation using qPCR shows that the fold-changes for
CCNA2, CYP17A1, and ECT2 are of similar magni
tude, while CYP19A1 is not different using either
method.
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Table 4
Select Differentially Regulated Genes in High A4 vs. Control Granulosa Cells.
Probeset
ID

Gene
Symbol

Description

Fold
Change

Control Avg
Expression

High A4 Avg
Expression

Location

Family

Function

12900052

TAAR6

6.98

13.71

105.88

CYP17A1

6.65

103.71

622.87

Plasma
Membrane
Cytoplasm

G-protein coupled
receptor
Enzyme

Signaling

12821429
12862676

TAS2R10

trace amine associated
receptor 6
cytochrome P450 family 17
subfamily A member 1
taste 2 receptor member 10

3.45

32.39

108.71

ALDH1A1

3.19

51.63

188.81

12822732

CHST15

2.53

274.23

711.00

Extracellular matrix

AS3MT
PRSS23

2.50
2.33

64.51
662.65

150.39
1540.76

Enzyme
Peptidase

Metabolism
Signaling

12751697

NDRG4

NDRG family member 4

2.32

314.15

719.73

Other

Signaling

12680976

ATP13A3

ATPase 13A3

2.14

756.15

1569.44

transporter

Ion transport

12846005

TTF2

− 2.01

127.55

63.38

12796835
12808472

KIF15
NDC80

− 2.04
− 2.08

254.74
359.29

133.83
175.67

Nucleus
Nucleus

transcription
regulator
Other
Other

Transcription and
transcription regulation
Mitosis
Mitosis

12755848

SLC7A5

− 2.09

127.48

64.86

Molecular transport

HIST1H4B

− 2.12

169.43

84.69

Plasma
Membrane
Nucleus

transporter

12802644

Other

Chromatin structure

12740526

NPHS2

transcription termination
factor 2
kinesin family member 15
NDC80, kinetochore complex
component
solute carrier family 7
member 5
histone cluster 1 H4 family
member b
NPHS2, podocin

Plasma
Membrane
Cytoplasm
Extracellular
Space
Plasma
Membrane
Extracellular
Space
Cytoplasm

Enzyme

12819205
12834667

aldehyde dehydrogenase 1
family member A1
carbohydrate sulfotransferase
15
arsenite methyltransferase
protease, serine 23

G-protein coupled
receptor
Enzyme

Signaling

12892676

Plasma
Membrane
Cytoplasm

− 2.13

126.72

56.27

Other

Protein-protein binding

12780541

IGFBP5

− 2.13

114.88

53.06

Other

Signaling

12722357
12718797

FBXO32
DSN1

− 2.15
− 2.17

153.06
152.07

81.06
73.77

Enzyme
Other

Protein degradation
Mitosis

12876902

HMMR

− 2.17

333.82

154.25

PARPBP
NCAPG

− 2.18
− 2.21

152.05
578.57

71.86
269.15

Plasma
Membrane
Nucleus
Nucleus

transmembrane
receptor
Other
Other

Signaling

12862370
12871525
12898870

PRSS35

insulin like growth factor
binding protein 5
F-box protein 32
DSN1 homolog, MIS12
kinetochore complex
component
hyaluronan mediated motility
receptor
PARP1 binding protein
non-SMC condensin I complex
subunit G
protease, serine 35

Plasma
Membrane
Extracellular
Space
Cytoplasm
Nucleus

− 2.23

174.20

76.46

Peptidase

Signaling

12825587
12692009

CENPU
NUSAP1

− 2.30
− 2.32

269.11
147.90

119.63
60.04

Other
Other

Chromatin structure
Mitosis

12805984

GMNN

− 2.34

121.91

51.56

Nucleus

KNTC1
JUN

− 2.35
− 2.36

329.52
482.69

144.28
208.88

Nucleus
Nucleus

12815755
12843247

KIF22
PHGDH

− 2.39
− 2.45

144.64
168.49

56.69
71.12

Nucleus
Cytoplasm

transcription
regulator
Other
transcription
regulator
Other
Enzyme

DNA replication

12745867
12835737

12894921

ESCO2

− 2.54

466.64

189.13

Nucleus

Enzyme

Mitosis

12877406

EGR1

centromere protein U
nucleolar and spindle
associated protein 1
geminin, DNA replication
inhibitor
kinetochore associated 1
Jun proto-oncogene, AP-1
transcription factor subunit
kinesin family member 22
phosphoglycerate
dehydrogenase
establishment of sister
chromatid cohesion Nacetyltransferase 2
early growth response 1

Extracellular
Space
Nucleus
Nucleus

− 2.83

700.86

253.77

Nucleus

12802519

HIST1H2BM

− 2.87

1055.36

397.45

Nucleus

Transcription and
transcription regulation
Chromatin structure

12687887

FOS

− 3.09

161.23

48.81

Nucleus

12905574

DYNLT3

− 3.13

121.89

39.77

Cytoplasm

transcription
regulator
Other

Transcription and
transcription regulation
Molecular transport

12774842
12761259

AOX1
SUMO2

histone cluster 1 H2B family
member m
Fos proto-oncogene, AP-1
transcription factor subunit
dynein light chain Tctex-type
3
aldehyde oxidase 1
small ubiquitin-like modifier 2

transcription
regulator
Other

− 3.30
− 5.21

274.91
955.58

81.15
222.36

Cytoplasm
Nucleus

Enzyme
Enzyme

Metabolism
Posttranslational
modification

interacting with TCF downstream of WNT signaling. Increased
CTNNBIP1 has been shown to cause cell cycle arrest and apoptosis in
certain cancers (Park et al., 2017). When GCs were treated with A4,
there was increased expression of mRNA abundance of CTNNBIP1
compared to controls (Fig. 8B).

Steroidogenesis

Metabolism

DNA repair
Mitosis

Mitosis
Transcription and
transcription regulation
Mitosis
Metabolism

Using Western blot analysis, the abundance of signal transduction
pathway proteins that regulate cell proliferation were measured in GCs
from EA dominant follicles, relative to ACTB. Non-phosphorylated
CTNNB1 (active beta catenin) (P < 0.02) was greater in High A4 GCs
(n = 9) compared to Control GCs (n = 17) (Fig. 8C) but no significant
7
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3.5. Comparison of high A4 GCs and luteal cell transcriptomes

Table 5
Ingenuity pathway analysis predicted inhibited functions based on all differen
tially up and down regulated granulosa cell genes.
Predicted Inhibited Functions in High A4 GCs

p-Value

# Molecules

Alignment of chromosomes
Cell survival
Cell viability
Cytokinesis
Interphase
M phase
Proliferation of cells
Repair of cells
Repair of DNA

1.42E-14
2.34E-04
2.36E-04
1.45E-07
3.10E-07
1.85E-11
2.02E-04
1.91E-03
1.16E-06

11
43
41
15
31
22
93
6
18

One major driver of gene expression profile change in GCs is the
luteinization process. To determine whether GCs in the High A4 follicles
were undergoing premature luteinization or other changes in their
cellular function, Principal Component Analysis (PCA) was performed
on the transcriptomes of the High A4 GCs, the Control GCs, and previ
ously published microarray data from large luteal cells (LLCs) and small
luteal cells (SLCs) (Fig. 9A) (Romereim et al., 2016). A graph of Principal
Component 1 (PC1, including 83.45% of the variance) on the X-axis and
PC2 on the Y-axis, shows that the distribution of the High A4 GCs along
the x-axis is shifted towards right falling between Control GCs and the
LLCs and SLCs; although, some of the High A4 GCs and Control GCs
overlap (Fig. 9B).
While the High A4 GCs do not cluster with either of the luteal cell
populations, a modest shift, suggests some luteal cell-like gene expres
sion patterns. Therefore, we compared gene expression in High A4
granulosa cells with our previously published PCA data that identified
genes that are enriched in LLCs or SLCs as well as genes common to
either the follicular cells (TCs and GCs) or luteal cells (LLCs and SLCs)
(Romereim et al., 2016). None of the genes specifically enriched in LLCs
or SLCs had significantly increased expression in the High A4 GCs
compared to the Control GCs. Also, there are only three genes that are
enriched in TCs that are significantly increased in expression in the High

differences were identified in relative protein abundance for phos
phorylated (inactive) CTNNB1, AKT1 (v-akt murine thymoma viral
oncogene homolog 1; also known as protein kinase B), phosphorylated
AKT1, FOXO1 (forkhead box O1), phosphorylated FOXO1, MAPK1/3
and MAPK1/3 (mitogen-activated protein kinase 1 and 3; also known as
ERK2 and ERK1), or phosphorylated MAPK1/3. There is the potential for
increased CTNNBIP1 protein to block WNT signaling, causing cell cycle
arrest or decreased proliferation. The increase in active beta catenin
(Fig. 8C) may be a compensatory mechanism to increase available
substrate to promote granulosa cell survival.

Fig. 5. Functions of differentially regulated genes. The functions of each differentially regulated gene as determined by Entrez and UniProt/KB annotations for (A)
the 60 upregulated transcripts in the High A4 GCs and (B) the 210 downregulated transcripts in the High A4 GCs compared to the Control GCs.
Fig. 6. Western blot quantification of GC
proliferation in cell culture. Primary GCs
pooled from large antral follicles of unclassified ovaries were cultured overnight
and then treated with basal media, FSH (0.1
IU/μL), or FSH and the indicated A4 con
centrations for 22 h (n = 3 wells per treat
ment X 2 slaughterhouse collections). An
ANOVA demonstrated an effect of androgen
on PCNA expression (P ≤ 0.05) (A) Western
blot quantification of the proliferation
marker PCNA normalized to beta actin
shows that FSH plus 1uM of A4 (286 ng/mL;
scale of A4 observed in High A4 cow domi
nant follicle ff) suppressed PCNA protein
detected in GCs indicating reduced prolifer
ation compared to GCs with no treatment.
Furthermore, FSH plus 1uM A4 (286 ng/mL)
had reduced PCNA when compared to FSH
plus 1 nM A4 (scale of A4 observed in Con
trol cow dominant follicle ff). (B) A repre

sentative blot is shown. *P < 0.04, **P < 0.01.
8
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Table 6
Differentially Regulated miRNA in High A4 vs. Control Granulosa Cells.
Probeset ID

Gene Symbol

Conserved miRNA Family

Description

Fold Change

Control GC Average

High A4 GC Average

12906595
12791562
12774048
12788834
12856465
12896347
12730564
12784970
12832475
12829226
12829236

MIR105A
MIR211
MIR2358
MIR2364
MIR2427
MIR2481
MIR326
MIR449B
MIR449D
MIR483
MIR584-7

miR-105–5p (and other miRNAs w/seed CAAAUGC)
miR-204–5p (and other miRNAs w/seed UCCCUUU)
Bovine-only, no known conserved family
Bovine-only, no known conserved family
Bovine-only, no known conserved family
Bovine-only, no known conserved family
miR-330–5p (and other miRNAs w/seed CUCUGGG)
miR-34a-5p (and other miRNAs w/seed GGCAGUG)
Bovine-only, no known conserved family
miR-483–3p (miRNAs w/seed CACUCCU)
miR-584–5p (and other miRNAs w/seed UAUGGUU)

bta-mir-105a
bta-mir-211
bta-mir-2358
bta-mir-2364
bta-mir-2427
bta-mir-2481
bta-mir-326
bta-mir-449b
bta-mir-449d
bta-mir-483
bta-mir-584-7

2.18
2.20
− 1.57
1.81
1.76
1.60
1.78
1.72
1.58
1.64
1.87

209.86
86.41
203.90
266.92
156.55
110.71
83.98
104.73
103.75
120.87
82.68

437.09
171.53
129.74
478.13
276.90
177.06
132.86
181.11
152.47
194.30
147.75

Fig. 7. Functions of predicted miRNA targets that are differentially regulated in High A4 GCs. The miRNAs, which were upregulated in High A4 GCs, had 112 unique
potential mRNA targets that were identified as differentially expressed in the microarray analysis. The functions of these mRNA targets as determined by Entrez and
UniProt/KB annotations are shown.

A4 GCs (COL4A1, AS3MT, and CYP17A1; Table 7).
However, there are several transcripts that are enriched in GCs are
differentially expressed in High A4 GCs (Data in Brief, Snider et al.,
XXXXXXXX). Two of these transcripts (NDRG4 and UNC79) had the
highest expression in the High A4 GCs compared to all other cell types
(luteal, thecal). Three transcripts (IGFBP5, SQRDL, and CYBRD1) had
the lowest expression in the High A4 GCs compared to other cell typesControl GC, luteal and thecal). All other genes were significantly lower
in the High A4 GCs than the Control GCs, which could lead to a shift
towards the expression levels seen in TCs, LLCs, and SLCs. This includes
the loss of expression of one of the suggested GC-specific markers:
RGS17 in High A4 GCs compared to Control GCs (Data in Brief, Snider
et al., XXXXXXXX). Interestingly, there were 74 differentially expressed
genes in High A4 GCs that were identified as enriched in luteal cell types
but not in follicular cells (Control GC and thecal). Alternatively, there
were 17 genes differentially expressed in High A4 GCs that are enriched
in follicular compared to luteal cells. Additionally, most of the genes
indicating a High A4 GC shift towards a luteal expression pattern were
those involved with mitosis and the cell cycle.

3.6. Localization of CYP17A1 and CYP19A1 expression in bovine
ovarian follicles
Because in vivo and in vitro data showed that excess androgens
inhibit cell proliferation, and because there was increased CYP17A1 in
High A4 granulosa cells, localization of enzymes that regulate androgens
(CYP17A1) and estrogens (CYP19A1) were determined using immuno
fluorescence. GCs from large antral follicles (>10 mm diameter) from 3
cows classified as Control and 3 cows classified as High A4 were
collected after FSH stimulation, affixed to slides via a Cytospin centri
fuge, and immunofluorescence was performed using antibodies against
both CYP17A1 and CYP19A1. Although expression of aromatase
(CYP19A1) in GCs was expected, expression of CYP17A1 was also pre
sent within GCs, independent of their androgen classification (High A4
or Control) (Fig. 10). To verify the presence of CYP17A1 protein in
bovine GCs, immunofluorescence was also conducted in large antral
follicles (>7 mm diameter, n = 3) isolated from un-classified ovaries
obtained from cows at a local abattoir. As expected, CYP17A1 expres
sion was localized to theca cells and CYP19A1 was localized to granulosa
cells. Unexpectedly, CYP17A1 expression was also localized to GCs
within antral follicles (Fig. 11). Based on the staining, there was
9
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Fig. 8. Altered expression of markers involved in
the WNT signaling pathway in High and Control
GCs. Primary GCs pooled from large antral follicles
of un-classified ovaries were cultured overnight and
then treated with media containing FSH (0.1 IU/μL)
as the control or with A4 (100 nM) as the treatment.
(A) ELISA-quantified AMH concentrations in GC
culture media increased in A4 treatment conditions
compared to controls. (B) CTNNBIP1 expression
was measured in GCs by ddPCR, and CTNNBIP1
expression was increased in A4-treated GCs
compared to controls. (C) Western blot analysis was
conducted to detect protein levels for GCs from
dominant, EA follicles. Beta actin (ACTB) was used
as an endogenous control. Means were compared
between GCs classified as High A4 (n = 9) and
Control (n = 17). Significant increased protein
expression of non-p-CTNNB1 was observed in High
A4 GCs compared to controls. *P < 0.05. p =
phosphorylated.

Fig. 9. Principal Component Analysis and Hierarchical Clustering of High and Control GCs compared to luteal cells. (A) Hierarchical clustering of the individual
samples within each cell type/group shows that SLCs and LLCs are similar to each other though distinguishable as a cell type, just as High A4 GCs and Control GCs are
similar but distinct. (B) The Eigenvalues for Principal Component 1 and Principal Component 2 are graphically represented to show the variability between samples.
The LLCs and SLCs (transcriptomes previously published in Romereim et al., 2016) cluster by cell type. The Control GCs and High A4 GCs overlap, though the High
A4 GCs are shifted towards the luteal cells based on Principal Component 1.
Table 7
Theca cell enriched genes with increased expression in high A4 GCs.
Probe Set
ID

Gene

Description

Fold Change (High
A4 GC vs Control
GC)

Expression
Pattern Shift

Functional
Category

Fold Change
(LLC vs GC)

Fold Change
(LLC vs TC)

Fold Change
(LLC vs SLC)

12711158

COL4A1

collagen type IV alpha 1 chain

1.588

Towards TC

2.13

2.736

3.405

12819205
12821429

AS3MT
CYP17A1

arsenite methyltransferase
cytochrome P450 family 17
subfamily A member 1

2.497
6.649

Towards TC
Towards TC

extracellular
matrix
metabolism
steroidogenesis

6.129
11.595

21.453
129.714

6.709
37.024

approximately 45% CYP17A1 and 55% CYP19A1 expression in gran
ulosa cells from the large antral follicles.

4. Discussion
4.1. Transcriptomes of granulosa cells are distinguishable by the
androstenedione content of the follicular microenvironment
Hierarchical clustering clearly distinguishes the transcriptomes of
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Fig. 10. CYP17A1 and CYP19A1 in bovine High A4 and Control GCs. Representative images of immunostaining for DAPI to identify nuclei (blue), as well as
CYP17A1 (green) and CYP19A1 (red) expression in GCs aspirated from large antral follicles (>10 mm diameter) of cows classified as Control (n = 3) or High A4 (n =
3) after FSH stimulation (Fig. 3). Merged images identify locations with dual CYP17A1 and CYP19A1 expression (yellow). Scale bar represents 10 μm.
Fig. 11. Localization of CYP17A1 and
CYP19A1 expression in bovine ovarian fol
licles. Representative images of immuno
staining for DAPI to identify nuclei (blue), as
well as CYP17A1 (green) and CYP19A1 (red)
expression in large antral follicles (>7 mm
diameter) isolated from the ovaries of unclassified cows collected at a local abattoir
(n = 3). There was approximately 45%
CYP17A1 and 55% CYP19A1 expression in
granulosa cells. Scale bar represents 20 μm.
GC, granulosa cells; TC, theca cells.

GCs of preovulatory antral follicles based on their A4 environment;
however, there are relatively few (270 total) transcripts that were
significantly different between the High A4 GC and Control GC micro
array (Fig. 4, Data in Brief, Snider et al., XXXXXXXX). The fact that most
of the transcriptome is similar between High A4 and Control GCs is not
surprising, as the samples are from the same cell type and within follicles
of the same stage. Interestingly, one of the transcripts with the greatest

increase (6.6 fold) in the High A4 GCs is CYP17A1 (Table 3). This,
combined with the fact that the expression of CYP19A1 was unchanged,
corresponds well with the previously identified increases in androgen
concentrations within antral follicles (Summers et al., 2014). This sug
gests that production of A4 by the GCs themselves could be contributing
to the local A4 excess.
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4.2. Proliferation of GCs are inhibited by a high-androstenedione
microenvironment

progression (Data in Brief, Snider et al., XXXXXXXX and Fig. 7). Some of
these miRNA are known to inhibit tumor cell proliferation including
miR-211 in ovarian epithelial cancer, miR-326 in brain tumors, miR449B in both ovarian and colon cancer, miR-483 in ovarian and other
squamous cell cancers, and miR-584 in various types of cancer (Bertero
et al., 2013; Chen, 2013; Kefas et al., 2009; Ma et al., 2011; Ueno et al.,
2011; Vriens et al., 2012; Wang et al., 2010; Xia et al., 2015; Zheng et al.,
2013). Further investigation is necessary, however, to elucidate the role
of these miRNA in a bovine ovarian follicle context.

Additional predicted functional consequences of a high-androgen
microenvironment were identified based on analysis of the microarray
data with IPA predictive algorithms. The largest category (23%) of
downregulated gene functions and the majority of the predicted
inhibited cell behaviors were related to mitosis, the cell cycle, and cell
proliferation (Fig. 5B, Table 5). Many of the downregulated gene func
tions that were not directly identified as controlling proliferation can
also be related to various aspects of the cell cycle such as DNA replica
tion and repair, chromatin structure, and cytoskeletal dynamics
(Fig. 5B). The upregulated gene functions were dominated by miRNA
(26%), signaling (17%), and immune function (14%) (Figs. 5A and 7).
Typically, GCs continue to proliferate until terminal differentiation
following the peri-ovulatory LH surge. The effects of A4 on GC prolif
eration have not been previously investigated, but proliferation of GCs in
vivo can be inhibited by exogenous dihydrotestosterone (DHT) in rats
(Kayampilly and Menon, 2012; Pradeep et al., 2002). Thus, to establish
whether the A4 concentrations were sufficient to cause inhibited pro
liferation, in vitro granulosa cell culture experiments were performed.
Treatment with A4 resulted in inhibition of granulosa cell proliferation
at the greatest A4 dose which was similar to that found in High A4
follicular fluid (Fig. 6) when compared to the untreated control group.
The three concentrations of A4 used in this study represent the average
A4 concentration in Control follicles (1 nM), an intermediate concen
tration (100 nM), and the highest A4 concentrations in follicles of the
High A4 population (1 μM). These results demonstrate that increased A4
is sufficient to cause the reduction in cell proliferation that was pre
dicted by changes in mRNA abundance. It may be that inhibition of GC
proliferation limits the number of cells in the GC population as a whole
and thus, reduces the conversion of theca-derived A4 to E2 (Summers
et al., 2014). Another potential reason for GC inhibition is due to the
increased A4 environment. A study by Billig et al. demonstrated gran
ulosa cells exposed to increased levels of androgens undergo autophagy
leading to apoptosis due to increased DNA fragmentation (Billig et al.,
1993). Therefore, suppressed GC proliferation may further contribute to
the local A4 accumulation and increased GC autophagy and apoptosis.

4.4. High-androstenedione microenvironments may alter cell signaling
pathways to compensate for altered steroidogenesis and proliferation
Steroidogenesis and proliferation in GCs are believed to require
CTNNB1, a transcriptional co-activator within the WNT signaling
pathway, which is inactivated and degraded upon phosphorylation
(Castanon et al., 2012; Hernandez Gifford et al., 2009; Liu et al., 2009).
Prior studies have documented a greater abundance of total CTNNB1 in
cultured bovine GCs following treatment with FSH, and knockdown of
CTNNB1 has been shown to inhibit the proliferation of cultured mouse
GCs (Castanon et al., 2012; Gupta, et al., 2014; Wang et al., 2010). In the
current study, FSH plus 1 μM A4 treatment inhibited proliferation of
cultured GCs, and microarray analysis of High A4 GCs indicated inhi
bition of the cell cycle. Consequently, we predicted that active CTNNB1
would be less abundant in High A4 GCs compared to Control A4 GCs.
However, active CTNNB1 was more abundant in High A4 GCs, sug
gesting that this increase may be a compensatory mechanism. We sug
gest this, because expression of CTNNBIP1 mRNA abundance (possibly
via increased AMH concentration) was observed in slaughterhouse
granulosa cells treated with FSH and A4 at concentrations seen in our
High A4 cow dominant follicle follicular fluid. The enhanced AMH and
CTNNBIP1 may lead to reductions in downstream WNT signaling effects
(Park et al., 2017).
In GCs, AMH binds to its receptor AMHR2 to regulate cellular pro
liferation and follicular progression (Poole et al., 2016). Increased AMH
concentration has been demonstrated to decrease aromatase (CYP19A1)
activity and inhibit the effects of FSH on follicular progression in rodents
and women with PCOS (Durlinger et al., 2001; Sacchi et al., 2015).
Along with decreasing the effect of FSH in GCs, AMH can increase the
expression of CTNNBIP1 transcripts. The expression of CTNNBIP1 can
inhibit the action of active CTNNB1 and decrease WNT signaling
pathway downstream effects (Tago et al., 2000). Reduction in WNT
signaling leads to increased GC arrest and inhibition of follicular pro
gression (Durlinger et al., 2001; Park et al., 2017). The increased con
centration of active CTNNB1 in the High A4 GC may represent a
compensatory response to reverse inhibition of granulosa cell prolifer
ation since normally active CTNNB1 translocates to the nucleus and
binds to other transcriptional regulators such as TCF to increase cellular
proliferation (Park et al., 2017) or SF1 (NR5A1) to regulate CYP19A1
(Parakh et al., 2006) and LHCGR expression (Law et al., 2013). CTNNB1
is predicted through the IPA upstream analysis to be inhibited in the
High A4 granulosa cells, however we have increased active CTNNB1.
Normally this increase would indicate that the cell is actively prolifer
ating through the WNT pathway upon binding of active CTNNB1 and
TCF. Elevated CTNNBIP1 can block WNT signal transduction by inhib
iting binding of TCF and active CTNNB1. Thus, we are hypothesizing
that elevated A4 concentrations are inducing AMH-associated
CTNNBIP1 expression, to block proliferation through WNT-active
CTNNB1-TCF mechanisms. The culmination of these events inhibits
the WNT pathway and may be a cause of the cell cycle arrest and
apoptosis in granulosa cells from the High A4 cows.

4.3. Potential regulators inhibiting GC proliferation
Besides A4 exposure itself, regulatory mechanisms resulting in
decreased proliferation were investigated. The IPA predictive software
was able to determine many signaling molecules, drugs, and signaling
mediators like kinases and phosphatases that could potentially cause
changes in transcript abundance (Data in Brief, Snider et al.,
XXXXXXXX). The software can also determine likely upstream regula
tors and/or inhibitors in the transcripts of interest. However, some of the
predicted molecules are unlikely to be present in the follicle, and others
do not correspond to known follicular conditions. For example, estrogen
is a predicted inhibited upstream regulator, but the estrogen concen
trations of the follicles were not lower in the High A4 cows and the
expression of the estrogen receptor mRNA is unchanged. There also
might be a problem in binding affinity of the estrogen receptor or
increased inhibitor production, however, these were not measured and
would need to be investigated further. Additionally, neither androgen
receptor nor any androgens are predicted upstream regulators as acti
vated by IPA. This may be due to the relative lack of known genetic/
molecular interactions for androgens in the IPA database compared to
estrogen and other molecules. Nevertheless, the predictions do provide
potential avenues of investigation for future assessments of the in vivo
phenotype.
In addition to the intracellular signaling mediators predicted by the
IPA upstream molecules algorithms, miRNA are possible drivers of the
inhibited GC proliferation. The ten miRNAs upregulated in the High A4
GCs could be acting on multiple mRNA targets to inhibit cell cycle

4.5. CYP17A1, CYP19A1 expression in bovine ovarian follicles
In GCs, the steroidogenesis pathway prior to ovulation involves the
conversion of A4 to estrogen with the enzyme aromatase (CYP19A1).
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These cells lack the capability to produce this androgen and require A4
produced by theca cells to synthesize estrogens. The enzyme, CYP17A1,
along with HSD3β is required to convert pregnenolone to A4. However,
recent studies have found a signaling pathway that causes a silence of
CYP17A1 in GCs, leading to increased expression of CYP19A1 and the
production of estrogen. FOS, an integral activator protein has been
demonstrated to be the key regulator of CYP17A1 expression in both
theca and granulosa cells, with increased expression in the granulosa
cells and the opposite in theca cells (Beshay et al., 2007; Patel et al.,
2009).
Patel et al. demonstrated that suppression of FOS expression in the
HGL5 human granulosa cell line results in robust increases in CYP17A1
promoter activity and protein expression (Patel et al., 2009). Other
studies with KGN cell lines and porcine GCs also demonstrated similar
results (Huang et al., 2016; Ye et al., 2017). A study by Shanker et al.,
determined increased secretion of androgens in prostatic cancer cells
suppresses the expression of FOS and JUN transcripts, leading to altered
androgen-receptor signaling (Shanker et al., 2016). Finally, FOS is under
expressed in adipose tissue of women diagnosed for PCOS and 3 SNP’s
within the FOS gene were significantly associated with PCOS suggesting
that individuals with these SNP’s were more susceptible for developing
PCOS (Jones et al., 2012).
Microarray analysis of control and High A4 GCs showed a 3-fold
down regulation of FOS and 2-fold down regulation of JUN in High A4
GCs and a 6-fold up-regulation of CYP17A1, which supports previous
reports of altered expression in GCs (Patel et al., 2009). The increased
concentration of A4 in follicular fluid of the High A4 cows might be a
potential pathway for A4-mediated downregulation of FOS and JUN,
resulting in upregulation of CYP17A1. Together, this provides support
that High A4 GCs have an altered signaling pathway leading to a loss of
identity of these cells.

(Romereim et al., 2016) had significantly increased expression in the
High A4 GCs, and there were only three genes that are TC-enriched
genes that were significantly increased in expression in the High A4
GCs (Data in Brief, Snider et al., XXXX). The lack of increased expression
in genes that are important cell type identifiers suggests that the High A4
GCs have lost their granulosa cell identity and are neither granulosa cells
nor luteal cells. This is further supported by 74 changes in expression of
genes in High A4 GCs that shifted expression towards the shared luteal
gene profiles, but there were also 17 genes indicating a shift in the
opposite direction away from luteal patterns. Most of the genes indi
cating a High A4 GC shift towards a luteal expression pattern were those
involved with mitosis and the cell cycle (with luteal cells being less
proliferative than pre-ovulatory GCs). For this reason, the High A4 GCs
appear to have lost their cellular function and identity.
Finally, it is possible is that the High A4 GCs are undergoing a change
that could lead to a persistent or cystic follicle. Bovine and rodent GCs in
persistent follicles or cysts have been shown to have GCs with reduced
proliferation (Isobe and Yoshimura, 2007; Salvetti et al., 2009). The
mechanisms driving inhibition of proliferation in GCs in both a high
androgen follicular environment and in the case of follicular persistence
will both benefit from further investigation.
4.7. Conclusions
The consequence of a high A4 microenvironment have been inves
tigated using a unique, naturally occurring bovine model of local
androgen excess. A thorough analysis of the transcriptomes of the GCs
from Control follicles and High A4 follicles has determined that a small
set of differentially represented transcripts has important biological
relevance to these cells. The High A4 GCs have the potential to
contribute to the A4 accumulation and are very likely experiencing
inhibited proliferation. Treatment of GCs with A4 in culture is sufficient
to decrease expression of the proliferation marker PCNA, increase AMH
production, and increase CTNNBIP1 expression. The increased expres
sion of CTNNBIP1 can lead to decreased downstream effects to inhibit
active CTNNB1 and the WNT signaling pathway, resulting in cell cycle
arrest. Additionally, potential upstream regulators of proliferation
including miRNA have been identified. Overall, the consequences of
excess androgens for GCs are primarily decreased proliferation and loss
of cell identity.

4.6. High-androstenedione microenvironments may drive partial
luteinization
A comparison between the transcriptomes of the High A4 GCs,
Control GCs, LLCs, and SLCs reveals differentially regulated transcripts
in High A4 GCs have a luteal-like expression pattern. However, there are
also other transcripts that are upregulated in High A4 GCs that appear to
be theca-specific (COL4A1, AS3MT, and CYP17A1; Table 7). We used
Principal Component Analysis (PCA) to visualize variability and identify
similarity of cell types. This analysis showed no clear clustering of the
High A4 GCs with either luteal cell type; but, does show a modest shift of
the High A4 GCs towards the luteal cells based on PCA 1, which repre
sents ~84% of the variability between cell types (Fig. 9). The fact that
some of the Control and High A4 GCs overlap in the PCA graph indicates
that either the differential gene expression in the High A4 GCs is not
robust enough to completely separate the two GC populations using
overall transcriptome data or a larger sample size is necessary to identify
clear clustering of High A4 GCs separate from Control GCs.
Further investigation into the High A4 GC identity was performed by
cross-referencing the set of genes differentially regulated in the High A4
GCs with published transcriptome data from the follicular (GC and TC)
and luteal (LLC and SLC) cells of the ovary (Romereim et al., 2016). It is
apparent that much of the GC-specific gene expression is lost in the High
A4 GC, but there are also no large increases in the expression of genes
enriched in luteal cell. Thus, the data does not directly implicate the
adoption of another cell identity. From the published list of transcripts
specifically enriched in GCs, the High A4 GCs have 87 GC markers with
altered expression in the High A4 GCs (Data in Brief, Snider et al.,
XXXX). Five transcripts were either highest or lowest fold-change dif
ferences in the High A4 GCs compared to all other cell populations,
indicating a shift away from all other cell types. The other genes were
expressed highest in the Control GCs, and the High A4 GCs lost magni
tude of expression bringing their expression levels closer to that of the
TCs, LLCs, and SLCs. However, none of the identified LLC or SLC markers
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